Compare Pacific Strategic Financial Tbk (APIC) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pacific Strategic Financial Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Pacific Strategic Financial Tbk trades at Rp575 (market cap 6.59T, 834.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Pacific Strategic Financial Tbk is far larger — about 10.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 834.1K). Which is the better fit depends on your goals.
| APIC | LABS | |
|---|---|---|
Market Cap | 6.59T | 635.95B |
Volume | 834.1K | 843K |
Lot | 8.34K | 8.43K |
Turnover | 462.05M | 137.6M |
Average Price | 553.95 | 163.22 |
Value | 462.05M | 137.6M |
Indicative Equilibrium Price | 575 | 165 |
Indicative Equilibrium Volume | 788 | 246 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pacific Strategic Financial Tbk
Founded in Jakarta on February 22nd 1989 as PT. Citramas Securindo. Name changed to be PT. Arta Pacific Securities on July 4th 2000. Conduct as broker dealer and underwriter in capital market.
Read more on APIC →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
